✦ LIBER ✦

PGI7 COST-EFFECTIVENESS OF PEGINTERFERON ALFA-2A (40KD) (PEGASYS®) COMPARED TO LAMIVUDINE AS FIRST LINE TREATMENT OF CHRONIC HEPATITIS B (CHB) IN THE UK

✍ Scribed by PL Veenstra; SD Sullivan; GM Dusheiko; M Jacobs; GJ Lewis; KK Patel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HBeAg-Negative Chronic Hepatitis B: Cost

✍ David L. Veenstra; Sean D. Sullivan; Ming-Yang Lai; Chuan-Mo Lee; Chia-Ming Tsai 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Cost-effectiveness of peginterferon alfa

✍ Sean D Sullivan; David L Veenstra; Pei-Jer Chen; Ting-Tsung Chang; Wan-Long Chua 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB

A comparison of cost-effectiveness of pe

✍ S.D. Sullivan; J. Green; K.K. Patel; A. Crtaxi; A. Alberti; G. Giuliani; C. De C 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Evidence for the efficacy of peginterfer

✍ W.Graham E. Cooksley; Teerha Piratvisuth; Yuan-Jen Wang; Varocha Mahachai; You-C 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 165 KB

PIN9 A COST UTILITY ANALYSIS OF PEGINTER

✍ NR Latimer; GJ Lewis 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

95 Peginterferon alfa-2A (40KD) (PEGASYS

✍ P. Marcellin; G.K.K. Lau; F. Bonino; P. Farci; S. Hadziyannis; R. Jin; Z.-M. Lu; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB